American Liberty Petroleum to Acquire Avant Diagnostics, Bring OvaDx Test to Market

Sep 18, 2014

|

NEW YORK (GenomeWeb) – American Liberty Petroleum Corp. has announced plans to acquire Avant Diagnostics, a Scottsdale, Ariz.-based company seeking to commercialize OvaDx, a microarray-based test for early stage ovarian cancer detection.

According to an 8-K filing with the US Securities and Exchange Commission, American Liberty Petroleum Corp. has signed a letter of intent to buy Avant for an undisclosed sum. The companies expect the deal to close on or about Oct. 1.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Of Mice and Microbes

Mice in New York harbor both antibiotic-resistant bacteria and novel viruses, according to a new analysis of their fecal microbiomes.

Guidelines for Genomics in Africa

Human Heredity and Health in Africa Initiative has issued guidelines for genomic research in the region, according to Nature News.

So Many Choices

The Associated Press reports that an ethicist predicts that prenatal diagnosis and other advances will lead to more choices being available to prospective parents.

This Week in Genome Biology

In Genome Biology this week: approach to analyze alternative polyadenylation, algorithm to predict transcriptomic structural variations, and more.

May

15

Featured Webinar

Reaping the Benefits of Algorithm-Driven Research in Synthetic Biology

This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.

Jun

20

Featured Webinar

Expert Tips on Sequencing and Library Prep from the Wellcome Sanger Institute

In this webinar, Michael Quail of the R&D Sequencing team at the Wellcome Trust Sanger Institute will provide an expert perspective on library prep for next-generation sequencing.

Jun

28

Featured Webinar

An Optimized NGS Workflow for Human Metagenomic Analysis

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.

Main menu